Additionally, increased tCho levels have been associated with overexpression of the HER-2/neu gene [9] and with aggressive phenotypes, such as triple-negative breast cancer (TNBC) [10, 11]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.